Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - OTHER CURRENT ASSETS
Other Current Assets RARE - Ultragenyx Pharmaceutical Inc.
40.3 M
LAST VALUE
-23.54%
2 YEAR CAGR
-4.75%
5 YEAR CAGR
13.01%
10 YEAR CAGR